• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌诊断对患者健康相关生活质量的影响。

The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life.

作者信息

Verma Manisha, Paik James M, Younossi Issah, Tan Daisong, Abdelaal Hala, Younossi Zobair M

机构信息

Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.

Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.

出版信息

Cancer Med. 2021 Sep;10(18):6273-6281. doi: 10.1002/cam4.4166. Epub 2021 Aug 18.

DOI:10.1002/cam4.4166
PMID:34405568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446553/
Abstract

BACKGROUND

Patients with hepatocellular cancer (HCC) are known to have worse health-related quality of life (HRQL) than the general population. However, the change in HRQL from before the diagnosis to after diagnosis remains unknown and is difficult to estimate. We aimed to compare HCC cases with matched controls to evaluate the differences in change in HRQL from before to after HCC diagnosis.

METHODS

We performed propensity score-matched analysis using the self-reported HRQL data from the Surveillance, Epidemiology, and End Results registries (SEER) data linked with Medicare Health Outcomes Survey (MHOS) data (1998-2014). Cases were selected as Medicare beneficiaries (aged ≥65 years) who were diagnosed with HCC between their baseline assessment and follow-up assessment. Matched controls were selected from the same data resource and the same time period to include subjects without cancer diagnosis by propensity scores. HRQL was assessed using the Medical Outcomes Study Short Form-36 (SF-36).

RESULTS

The study included 62 subjects who developed HCC and 365 matched controls. Compared to their baseline HRQL scores, after diagnosis of HCC, subjects were more likely to report declines in scores related to the mental component of HRQL. When stratified by time since diagnosis, mental component remained significantly lower as the disease advanced. In contrast, only general health aspects of physical health worsened after HCC diagnosis.

CONCLUSIONS

Diagnosis of HCC has a profound negative impact on patients' HRQL. Mental health component deteriorated significantly over time. The need of including mental health services within a multidisciplinary HCC care model is clearly evident.

摘要

背景

已知肝细胞癌(HCC)患者的健康相关生活质量(HRQL)比普通人群更差。然而,从诊断前到诊断后HRQL的变化仍不清楚且难以估计。我们旨在比较HCC病例与匹配的对照组,以评估HCC诊断前后HRQL变化的差异。

方法

我们使用来自监测、流行病学和最终结果登记处(SEER)数据与医疗保险健康结果调查(MHOS)数据(1998 - 2014年)相链接的自我报告HRQL数据进行倾向评分匹配分析。病例被选为在基线评估和随访评估之间被诊断为HCC的医疗保险受益人(年龄≥65岁)。匹配的对照组从相同的数据资源和相同的时间段中选择,以纳入通过倾向评分未被诊断患有癌症的受试者。使用医疗结果研究简表36(SF - 36)评估HRQL。

结果

该研究包括62名发生HCC的受试者和365名匹配的对照组。与他们的基线HRQL评分相比,在诊断为HCC后,受试者更有可能报告与HRQL心理成分相关的评分下降。按诊断后的时间分层时,随着疾病进展,心理成分仍然显著较低。相比之下,HCC诊断后仅身体健康的总体健康方面恶化。

结论

HCC的诊断对患者的HRQL有深远的负面影响。心理健康成分随时间显著恶化。在多学科HCC护理模式中纳入心理健康服务的必要性显而易见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b847/8446553/e1dfc3d05d88/CAM4-10-6273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b847/8446553/e1dfc3d05d88/CAM4-10-6273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b847/8446553/e1dfc3d05d88/CAM4-10-6273-g002.jpg

相似文献

1
The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life.肝细胞癌诊断对患者健康相关生活质量的影响。
Cancer Med. 2021 Sep;10(18):6273-6281. doi: 10.1002/cam4.4166. Epub 2021 Aug 18.
2
Health-related quality of life: Hepatocellular carcinoma, chronic liver disease, and the general population.健康相关生活质量:肝细胞癌、慢性肝病与普通人群。
Qual Life Res. 2007 Mar;16(2):203-15. doi: 10.1007/s11136-006-9111-2. Epub 2006 Nov 21.
3
Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.根治性膀胱切除术对健康相关生活质量的影响:来自医疗保险健康结果调查的比较分析。
J Urol. 2018 Mar;199(3):669-675. doi: 10.1016/j.juro.2017.08.111. Epub 2017 Sep 5.
4
Impact of cancer on health-related quality of life of older Americans.癌症对美国老年人健康相关生活质量的影响。
J Natl Cancer Inst. 2009 Jun 16;101(12):860-8. doi: 10.1093/jnci/djp123. Epub 2009 Jun 9.
5
Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.前列腺癌主动监测与健康相关的生活质量:前瞻性试验芬兰部分的结果。
BJU Int. 2012 Jun;109(11):1614-9. doi: 10.1111/j.1464-410X.2011.10677.x. Epub 2011 Nov 1.
6
Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.肝细胞癌(HCC)和肝硬化患者的精神病理学特征与健康相关生活质量(HRQOL)
Clin Exp Med. 2015 Feb;15(1):65-72. doi: 10.1007/s10238-013-0267-0. Epub 2013 Dec 10.
7
Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization.肝切除或经动脉化疗栓塞术后中期肝细胞癌患者的健康相关生活质量
Asian Pac J Cancer Prev. 2015;16(10):4451-6. doi: 10.7314/apjcp.2015.16.10.4451.
8
A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma.肝细胞癌切除术后生活质量的前瞻性纵向研究。
Arch Surg. 2001 Jun;136(6):693-9. doi: 10.1001/archsurg.136.6.693.
9
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
10
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.索拉非尼在晚期肝细胞癌中的疗效
Oncologist. 2016 Sep;21(9):1113-20. doi: 10.1634/theoncologist.2015-0478. Epub 2016 May 16.

引用本文的文献

1
Determinants of Health-Related Quality of Life After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Systematic Review.肝细胞癌患者经动脉化疗栓塞术后健康相关生活质量的决定因素:一项系统评价
J Clin Med. 2025 Jun 3;14(11):3941. doi: 10.3390/jcm14113941.
2
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.接受钇-90微球选择性体内放射治疗(SIRT)和纳武单抗治疗的不可切除肝细胞癌患者的健康相关生活质量:NASIR-HCC试验的亚组分析
J Patient Rep Outcomes. 2025 Apr 8;9(1):39. doi: 10.1186/s41687-025-00873-6.
3

本文引用的文献

1
Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review.美国肝细胞癌的流行病学、人文和经济负担:一项系统文献综述
Hepat Oncol. 2020 Jul 21;7(3):HEP27. doi: 10.2217/hep-2020-0024.
2
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference.肝细胞癌的试验设计与终点:美国肝病研究学会共识会议
Hepatology. 2021 Jan;73 Suppl 1:158-191. doi: 10.1002/hep.31327. Epub 2020 Sep 9.
3
Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets.
改善肝细胞癌患者与健康相关的生活质量:评估患者报告结局和干预靶点的关键方法
J Hepatocell Carcinoma. 2025 Mar 5;12:497-511. doi: 10.2147/JHC.S347929. eCollection 2025.
4
Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy.肝癌切除术患者肿瘤相关精神症状与健康行为对生活质量动态变化的影响。
Support Care Cancer. 2024 Aug 14;32(9):589. doi: 10.1007/s00520-024-08790-y.
5
Stigmatization of drinking patients with liver cancer: The role of socioeconomic status.肝癌饮酒患者的污名化:社会经济地位的作用。
Heliyon. 2024 Apr 2;10(7):e29105. doi: 10.1016/j.heliyon.2024.e29105. eCollection 2024 Apr 15.
6
Targeting Underlying Inflammation in Carcinoma Is Essential for the Resolution of Depressiveness.针对癌的潜在炎症是解决抑郁的关键。
Cells. 2023 Feb 23;12(5):710. doi: 10.3390/cells12050710.
7
Disparities in Hepatocellular Cancer Screening in Cirrhotic Patients With Psychiatric Disorders.患有精神疾病的肝硬化患者在肝细胞癌筛查方面的差异。
Cureus. 2022 Mar 26;14(3):e23516. doi: 10.7759/cureus.23516. eCollection 2022 Mar.
SEER-Medicare 数据最新概述:增强的内容和应用。
J Natl Cancer Inst Monogr. 2020 May 1;2020(55):3-13. doi: 10.1093/jncimonographs/lgz029.
4
Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.2009 年至 2018 年评估肝细胞癌患者健康相关生活质量的研究的系统评价。
Korean J Radiol. 2020 Jun;21(6):633-646. doi: 10.3348/kjr.2019.0808.
5
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
6
Trends in Racial/Ethnic Disparity of Health-Related Quality of Life in Older Adults with and without Cancer (1998-2012).1998 年至 2012 年间,癌症患者和非癌症患者健康相关生活质量的种族/民族差异趋势。
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1188-1195. doi: 10.1158/1055-9965.EPI-19-0819. Epub 2020 Mar 13.
7
Annual report to the nation on the status of cancer, part I: National cancer statistics.国家癌症报告:癌症现状年度报告第一部分:国家癌症统计数据。
Cancer. 2020 May 15;126(10):2225-2249. doi: 10.1002/cncr.32802. Epub 2020 Mar 12.
8
Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years.《国家癌症报告:20-49 岁男性和女性癌症现状》
J Natl Cancer Inst. 2019 Dec 1;111(12):1279-1297. doi: 10.1093/jnci/djz106.
9
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.年龄独立的生存获益:诊断时无转移的肝细胞癌(HCC)患者的基于人群研究。
Gut. 2020 Jan;69(1):168-176. doi: 10.1136/gutjnl-2018-318193. Epub 2019 Mar 16.
10
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.